$1.205
+0.015 (+1.26%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Perspective Therapeutics, Inc. (CATX) Moving Averages Convergence Divergence (MACD) indicator is -0.35, suggesting CATX is Strong sell.
Perspective Therapeutics, Inc. (CATX) 20-Day simple moving average is 2.21, while Perspective Therapeutics, Inc. (CATX) share price is $—, making it Sell.
Perspective Therapeutics, Inc. (CATX) 60-Day simple moving average is 2.73, while Perspective Therapeutics, Inc. (CATX) share price is $—, making it Sell.
Technical Analysis for CATX
AI Technical CATXAs of 2026-10-24, the technical board for Perspective Therapeutics, Inc. (CATX) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $1.25 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 23.647, MACD stands at -0.355 (Sell), Stochastic %K stands at 8.224 (Buy), Stochastic %D stands at 7.272 and CCI stands at -202.546 (Buy).
CATX trades below the 60-day SMA (2.73) and below the 200-day SMA (3.55). Immediate resistance sits at Classic R1 2.50, then R2 3.12. Support sits at Classic S1 1.16, then S2 0.44.
Perspective Therapeutics, Inc. (CATX) Support & Resistance Level
Perspective Therapeutics, Inc. (CATX) Technical Indicators
2026-10-24
| Name | Value |
|---|---|
| RSI_14 | 23.647 |
| STOCHk_14_3_3 | 8.224 |
| STOCHd_14_3_3 | 7.272 |
| CCI_20 | -202.546 |
| AO_5_34 | -0.849 |
| MOM_10 | -0.990 |
| MACD_12_26_9 | -0.355 |
Perspective Therapeutics, Inc. (CATX) Relative Strength Index (RSI_14) is 23.647, creating a Buy signal.
Perspective Therapeutics, Inc. (CATX) Stochastic %K is 8.224, creating a Buy signal.
Perspective Therapeutics, Inc. (CATX) Stochastic %D is 7.272, creating a Buy signal.
Perspective Therapeutics, Inc. (CATX) CCI_20 is -202.546, creating a Buy signal.
Perspective Therapeutics, Inc. (CATX) Awesome Oscillator (AO) is -0.849, creating a Sell signal.
Perspective Therapeutics, Inc. (CATX) Momentum (MOM) is -0.990, creating a Sell signal.
Perspective Therapeutics, Inc. (CATX) Moving Average Convergence Divergence (MACD) is -0.355, creating a Sell signal.
Perspective Therapeutics, Inc. (CATX) Moving Average
2026-10-24
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.504 | Sell |
| MA_10 | 1.882 | Sell |
| MA_20 | 2.205 | Sell |
| MA_60 | 2.732 | Sell |
| MA_200 | 3.554 | Sell |
| MA_250 | 3.339 | Sell |
Perspective Therapeutics, Inc. (CATX) 5-Day simple moving average is 1.504, while Perspective Therapeutics, Inc. (CATX) share price is $, making it a Sell.
Perspective Therapeutics, Inc. (CATX) 10-Day simple moving average is 1.882, while Perspective Therapeutics, Inc. (CATX) share price is $, making it a Sell.
Perspective Therapeutics, Inc. (CATX) 20-Day simple moving average is 2.205, while Perspective Therapeutics, Inc. (CATX) share price is $, making it a Sell.
Perspective Therapeutics, Inc. (CATX) 60-Day simple moving average is 2.732, while Perspective Therapeutics, Inc. (CATX) share price is $, making it a Sell.
Perspective Therapeutics, Inc. (CATX) 200-Day simple moving average is 3.554, while Perspective Therapeutics, Inc. (CATX) share price is $, making it a Sell.
Perspective Therapeutics, Inc. (CATX) 250-Day simple moving average is 3.339, while Perspective Therapeutics, Inc. (CATX) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.